ES8403877A1 - Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol. - Google Patents

Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol.

Info

Publication number
ES8403877A1
ES8403877A1 ES515766A ES515766A ES8403877A1 ES 8403877 A1 ES8403877 A1 ES 8403877A1 ES 515766 A ES515766 A ES 515766A ES 515766 A ES515766 A ES 515766A ES 8403877 A1 ES8403877 A1 ES 8403877A1
Authority
ES
Spain
Prior art keywords
mercapto
imidazole derivatives
preparation
substituted
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515766A
Other languages
English (en)
Other versions
ES515766A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8403877A1 publication Critical patent/ES8403877A1/es
Publication of ES515766A0 publication Critical patent/ES515766A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE MERCAPTOIMIDAZOL, DE FORMULA GENERAL (I), EN LA QUE COMO MINIMO UNO DE LOS RESTOS R1 Y R2 SIGNIFICA UN GRUPO HETEROARILO Y EL OTRO SIGNIFICA ARILO; R3 SIGNIFICA HIDROGENO O ALQUILO INFERIOR; N ES 0, 1 O 2; Y R4 SIGNIFICA UN RESTO DE HIDROCARBURO ALIFATICO, Y SUS SALES DE ADICION DE ACIDO.CONSISTE EN HACER REACCIONAR ENTRE SI COMPUESTOS DE FORMULAS (II) Y (III), EN LAS QUE X E Y SIGNIFICAN MERCAPTO UNO DE ELLOS Y EL OTRO SIGNIFICA UN RESTO INTERCAMBIABLE POR MERCAPTO ETERADO; Y R1, R2, R3 Y R4 TIENEN LOS SIGNIFICADOSYA MENCIONADOS.DE APLICACION EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS, ESPECIALMENTE DE INFLAMACIONES CRONICAS DEL TIPO REUMATICO.
ES515766A 1978-04-11 1982-09-16 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol. Granted ES515766A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU79412 1978-04-11

Publications (2)

Publication Number Publication Date
ES8403877A1 true ES8403877A1 (es) 1984-04-01
ES515766A0 ES515766A0 (es) 1984-04-01

Family

ID=19728887

Family Applications (5)

Application Number Title Priority Date Filing Date
ES479490A Granted ES479490A0 (es) 1978-04-11 1979-04-10 Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.
ES515766A Granted ES515766A0 (es) 1978-04-11 1982-09-16 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol.
ES528579A Granted ES528579A0 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ES528580A Expired ES8504738A1 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ES528581A Granted ES528581A0 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES479490A Granted ES479490A0 (es) 1978-04-11 1979-04-10 Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES528579A Granted ES528579A0 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ES528580A Expired ES8504738A1 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ES528581A Granted ES528581A0 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol

Country Status (24)

Country Link
US (3) US4461770A (es)
EP (1) EP0004648B1 (es)
JP (1) JPS54135769A (es)
KR (2) KR820002314B1 (es)
AT (1) AT376971B (es)
AU (1) AU532402B2 (es)
CS (1) CS220324B2 (es)
CY (1) CY1302A (es)
DD (1) DD142712A5 (es)
DE (1) DE2963572D1 (es)
DK (1) DK148879A (es)
ES (5) ES479490A0 (es)
FI (1) FI65066C (es)
GR (1) GR71193B (es)
HK (1) HK87285A (es)
HU (1) HU182018B (es)
IL (1) IL57040A (es)
MY (1) MY8600271A (es)
NO (1) NO148926C (es)
NZ (1) NZ190153A (es)
PL (2) PL125972B1 (es)
PT (1) PT69460A (es)
SU (2) SU1259962A3 (es)
ZA (1) ZA791702B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3025484A1 (de) * 1980-07-03 1982-02-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
US4780470A (en) * 1986-08-19 1988-10-25 Smithkline Beckman Corporation Inhibition of interleukin-1 by monocytes and/or macrophages
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
US5955480A (en) * 1996-11-20 1999-09-21 Merck & Co., Inc. Triaryl substituted imidazoles, compositions containing such compounds and methods of use
UA65572C2 (en) * 1997-04-24 2004-04-15 Ortho Mcneil Pharm Inc Substituted imidazoles, intermediate compounds for the preparation thereof, a method for the preparation of substituted imidazoles and a method for the treatment of inflammatory diseases
US6040320A (en) * 1997-06-30 2000-03-21 Ortho-Mcneil Pharmaceutical, Inc. 2-substituted imidazoles useful in the treatment of inflammatory diseases
DE19842833B4 (de) * 1998-09-18 2005-04-14 Merckle Gmbh 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung
DE10107683A1 (de) * 2001-02-19 2002-08-29 Merckle Gmbh Chem Pharm Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
DE10238045A1 (de) * 2002-08-20 2004-03-04 Merckle Gmbh Chem.-Pharm. Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
EP1904066B1 (en) 2005-07-06 2018-05-23 Sunovion Pharmaceuticals Inc. COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
AU2007233041B2 (en) * 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
EP1894925A1 (en) * 2006-08-24 2008-03-05 Merckle Gmbh Imidazole compounds having an antiinflammatory effect

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981739A (en) * 1958-01-27 1961-04-25 Diamond Alkali Co Certain alpha-haloaldehyde addition products of ethylenethioureas and process
US3714179A (en) * 1970-09-08 1973-01-30 Searle & Co 1-alkyl-2-furfurylthioimidazoles and congeners
JPS5343958B2 (es) * 1972-07-29 1978-11-24
SE428686B (sv) * 1975-08-11 1983-07-18 Du Pont Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
US4159338A (en) * 1977-02-09 1979-06-26 E. I. Du Pont De Nemours And Company Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones
DK16778A (da) * 1977-02-09 1978-08-10 Du Pont Imidazolderivater deres anvendelser og fremstilling
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4308277A (en) * 1978-08-10 1981-12-29 Ciba-Geigy Corporation 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions containing same
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
AT376971B (de) 1985-01-25
US4608382A (en) 1986-08-26
HU182018B (en) 1983-12-28
KR820002315B1 (ko) 1982-12-17
ES8504737A1 (es) 1985-05-01
PL125882B1 (en) 1983-06-30
FI791158A (fi) 1979-10-12
ES528579A0 (es) 1985-05-01
NO148926C (no) 1984-01-11
PL125972B1 (en) 1983-06-30
AU4599479A (en) 1979-10-18
KR820002314B1 (ko) 1982-12-17
MY8600271A (en) 1986-12-31
JPS54135769A (en) 1979-10-22
DD142712A5 (de) 1980-07-09
US4461770A (en) 1984-07-24
SU1259962A3 (ru) 1986-09-23
NO791228L (no) 1979-10-12
ES8303355A1 (es) 1983-02-01
EP0004648B1 (de) 1982-08-25
FI65066B (fi) 1983-11-30
ATA266179A (de) 1984-06-15
DK148879A (da) 1979-10-12
SU991945A3 (ru) 1983-01-23
ES479490A0 (es) 1983-02-01
HK87285A (en) 1985-11-15
ES515766A0 (es) 1984-04-01
ZA791702B (en) 1980-04-30
ES8505352A1 (es) 1985-05-16
US4584310A (en) 1986-04-22
FI65066C (fi) 1984-03-12
DE2963572D1 (en) 1982-10-21
NO148926B (no) 1983-10-03
JPS6339594B2 (es) 1988-08-05
ES528580A0 (es) 1985-05-01
CY1302A (en) 1985-12-06
PT69460A (en) 1979-05-01
AU532402B2 (en) 1983-09-29
CS220324B2 (en) 1983-03-25
IL57040A0 (en) 1979-07-25
NZ190153A (en) 1981-05-15
GR71193B (es) 1983-04-11
EP0004648A2 (de) 1979-10-17
ES528581A0 (es) 1985-05-16
EP0004648A3 (en) 1979-11-14
ES8504738A1 (es) 1985-05-01
IL57040A (en) 1984-08-31
PL214745A1 (es) 1980-06-16

Similar Documents

Publication Publication Date Title
ES473451A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES8303355A1 (es) Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.
ES8401466A1 (es) Procedimiento para la obtencion de derivados de piridina.
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
ES8700660A1 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
ES439927A1 (es) Procedimiento para la obtencion de 7-metoxi-6-tiatetracicli-nas.
ES8205791A1 (es) Procedimiento para la preparacion de derivados de imidazol del sistema de 1,4-benzodioxan-2-ilo
ATE21101T1 (de) N-iminopyridinium-betain-derivate, ihre herstellung und ihre verwendung als arzneimittel.
ES480111A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES474367A1 (es) Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
ES8301895A1 (es) "procedimiento para preparar nuevos acidos 2-amino-3-(halobenzoil)-metilfenilaceticos,sus esteres y sus sales metalicas".
ATE18211T1 (de) Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.
ES483247A1 (es) Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos
ES8300116A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina
ES8103740A1 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina
NO855383L (no) Fremgangsmaate for fremstilling av piperazin-derivater.
ES445343A1 (es) Procedimiento para la preparacion de derivados cuaternarios de xantinil-alcohil-nortropina.
ES479033A1 (es) Un procedimiento para la preparacion de derivados de n-iminometil piperidina.
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
ES488388A1 (es) Procedimiento de preparacion de derivados hidroxilados del tiazol
ES481416A1 (es) Un procedimiento para la preparacion de un derivado monoami-da de acido tereftalico.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991108